Novavax, Inc. (NVAX): Price and Financial Metrics


Novavax, Inc. (NVAX)

Today's Latest Price: $131.46 USD

4.48 (3.53%)

Updated Jan 25 6:55pm

Add NVAX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 484 in Biotech

See all "A" rated Strong Buy stocks

NVAX Stock Summary

  • The price/operating cash flow metric for Novavax Inc is higher than 95.78% of stocks in our set with a positive cash flow.
  • NVAX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 98.79% of US stocks.
  • Revenue growth over the past 12 months for Novavax Inc comes in at 1,181.88%, a number that bests 99.31% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Novavax Inc, a group of peers worth examining would be DRNA, CTMX, NKTR, XNCR, and AGIO.
  • Visit NVAX's SEC page to see the company's official filings. To visit the company's web site, go to www.novavax.com.

NVAX Stock Price Chart Interactive Chart >

Price chart for NVAX

NVAX Price/Volume Stats

Current price $131.46 52-week high $189.40
Prev. close $126.98 52-week low $6.26
Day low $125.14 Volume 3,010,900
Day high $131.50 Avg. volume 3,209,487
50-day MA $116.75 Dividend yield N/A
200-day MA $93.89 Market Cap 8.37B

Novavax, Inc. (NVAX) Company Bio


Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.


NVAX Latest News Stream


Event/Time News Detail
Loading, please wait...

NVAX Latest Social Stream


Loading social stream, please wait...

View Full NVAX Social Stream

Latest NVAX News From Around the Web

Below are the latest news stories about Novavax Inc that investors may wish to consider to help them evaluate NVAX as an investment opportunity.

Government of Canada fnalizes advance purchase agreement for COVID-19 Vaccine with Novavax

Novavax (NVAX) finalizes an agreement with the Government of Canada to supply up to 76M doses of NVX-CoV2373, the company’s recombinant protein-based COVID-19 vaccine.Canada has committed to purchase 52M doses of the vaccine with the option for up to an additional 24M doses.NVX-CoV2373 is currently in Phase 3 clinical development for the...

Seeking Alpha | January 22, 2021

Government Canada fnalizes advance purchase agreement for COVID-19 Vaccine with Novavax

Novavax (NASDAQ:NVAX) finalizes an agreement with the Government of Canada to supply up to 76M doses of NVX-CoV2373, the company’s recombinant protein-base

Seeking Alpha | January 22, 2021

UC Davis Health Novavax vaccine trials prioritize high-risk populations including minority groups - The Aggie

UC Davis Health Novavax vaccine trials prioritize high-risk populations including minority groups As UC Davis Health begins phase three of

The California Aggie | January 22, 2021

Curevac, Novavax start phase III COVID-19 clinical trials in Mexico, says government | Health

Read more about Curevac, Novavax start phase III COVID-19 clinical trials in Mexico, says government on Devdiscourse

Devdiscourse | January 22, 2021

Novavax Names Madelyn Caltabiano Senior Vice President, Global Program Management - Stocks News Feed

GAITHERSBURG, Md., Jan. 22, 2021 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Madelyn ‘Lyn’ Caltabiano, Ph.D. to the position of Senior Vice President, Global Program Management. In this newly created role, Dr. Caltabiano will lead and expand the Global… Read More »Novavax Names Madelyn Caltabiano Senior Vice President, Global Program Management

Stocks News Feed | January 22, 2021

Read More 'NVAX' Stories Here

NVAX Price Returns

1-mo N/A
3-mo 61.64%
6-mo -10.34%
1-year 1,446.59%
3-year 214.50%
5-year 34.97%
YTD 17.89%
2020 2,701.76%
2019 -89.18%
2018 48.39%
2017 -1.59%
2016 -84.98%

Continue Researching NVAX

Want to see what other sources are saying about Novavax Inc's financials and stock price? Try the links below:

Novavax Inc (NVAX) Stock Price | Nasdaq
Novavax Inc (NVAX) Stock Quote, History and News - Yahoo Finance
Novavax Inc (NVAX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8524 seconds.